>
The $50/SqFt House: Why People Are Building Quonset Homes
Man Builds a Root Cellar With a Greenhouse on Top | Start to Finish by @puremichiganliving9952
They Will Turn Your Money Off! Incoming Stablecoins More Dangerous Than CBDCs - Fitts
10 Delicious Ways to Preserve Tomatoes
NASA Super Light Solar Sail Project Will Be 12-40 Times Lighter and Faster
Space Telescope Interferometer to Image Exoplanet Continents
Twenty-five years of "temporary": how 9/11 built a surveillance state Americans never vote
I'll Never Buy Another WALMART Battery!
Shoei GT-Air 3 Smart helmet drops with built-in AR for $1,500
Freezable titanium plate keeps your cooler chilled way longer than ice packs
Review: Affordable thermal device is made for discovering life outdoors
AI Whistleblower Tells Tucker How AI Could Kill All Humans by 2040

Now a new study has found an intriguing piece of evidence supporting this hypothesis in genomes from several families that seem to be particularly prone to cancer.
In a way, our cells have a pre-determined number of divisions in their lifetime – around 50. That limit is dictated by our telomeres, small repeating segments of "junk" DNA that form caps on the ends of our chromosomes. These act like a buffer protecting the important DNA in the chromosomes from damage when a cell divides, but a little piece of the telomere is lost each time.
Eventually that damage adds up and the telomeres shorten to the point that the cell stops dividing. This contributes to the symptoms of aging that we're all too familiar with.
In theory, lengthening our telomeres or preventing them from shrinking should help slow the aging process, or even reverse it. Indeed, plenty of research is investigating this angle. But there's a nasty potential downside to doing so – cancer.
Cancer cells are effectively immortal, in the sense that they never stop dividing. It appears that having telomeres of a set length is an evolutionary defense mechanism to prevent that kind of runaway growth. And the new study has found more evidence supporting that hypothesis.
Researchers at the Rockefeller University and the Radboud University Medical Center studied the genomes of several Dutch families that appeared to be quite cancer-prone. Common among these patients were mutations in a gene called TINF2, which codes for a protein previously linked to telomere length.
So the team used CRISPR to engineer human cells with the same mutations, and found that they had much longer telomeres than usual. When the scientists checked the patients themselves, these little caps were also found to be particularly long.